Law Offices of Howard G. Smith reminds investors of the June 19,
2018 deadline to file a lead plaintiff motion in the class action
filed on behalf of investors that purchased Myriad Genetics, Inc.
(“Myriad” or the “Company”) (NASDAQ: MYGN)
securities between August 13, 2014 through March 12, 2018, inclusive
(the “Class Period”). Myriad investors have until June 19, 2018 to
file a lead plaintiff motion.
Investors suffering losses on their Myriad investments are encouraged to
contact the Law Offices of Howard G. Smith to discuss their legal rights
in this class action at 888-638-4847 or by email to firstname.lastname@example.org.
On March 12, 2018, Myriad disclosed that it received a subpoena from the
Department of Health and Human Services in connection with an
investigation into possible false Medicare and Medicaid payment claims.
The subpoena purportedly requested documents “relating primarily to the
Company’s billing to government-funded healthcare programs for the
Company’s hereditary cancer testing.”
On this news, Myriad’s share price fell $4.01 per share, or 12.1%, to
close at $29.01 per share on March 13, 2018, thereby injuring investors.
The complaint filed in this class action alleges that Defendants made
materially false and/or misleading statements and/or failed to disclose
that: (1) Myriad was submitting false or otherwise improper claims for
payment under Medicare and Medicaid for Myriad’s hereditary cancer
testing; (2) the foregoing conduct would foreseeably subject Myriad to
heightened regulatory scrutiny and/or enforcement action; (3) Myriad’s
revenues from its hereditary cancer testing were in part the product of
improper conduct and unlikely to be sustainable; and (4) as a result,
Myriad’s public statements were materially false and misleading at all
If you purchased shares of Myriad during the Class Period you may move
the Court no later than June 19, 2018 to ask the Court to
appoint you as lead plaintiff. To be a member of the Class you need not
take any action at this time; you may retain counsel of your choice or
take no action and remain an absent member of the Class. If you wish
to learn more about this action, or if you have any questions concerning
this announcement or your rights or interests with respect to these
matters, please contact Howard G. Smith, Esquire, of Law Offices of
Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania
19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by
email to email@example.com,
or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180618006091/en/